Company / Current Liabilities
Revolution Medicines, Inc. Current Liabilities History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities
$290.4M
FY2025
5-year range
$60.4M / $290.4M
FY2021-FY2025
Trend
+77.2%
vs FY2024
Sector context
#47 of 213
Health Care
What the data says
Revolution Medicines, Inc.'s current liabilities of $290M is higher than 78% of companies in the Health Care sector (FY2025). Current Liabilities has increased for 6 consecutive years, from $43M in FY2019 to $290M in FY2025.
Based on SEC 10-K filings.
$290M in FY2025 with a 5-year CAGR of +43.8%. Top quartile in the Health Care sector.
Increased from $144M to $290M over the past 2 years.
Health Care sector context is included.
Current Liabilities over time
Growth rates
- 3-Year CAGR
- +67.3%
- 5-Year CAGR
- +43.8%
- 10-Year CAGR
- -
Sector benchmark
-81.7% below sector average
Key checks
Key Insights
- Revolution Medicines, Inc.'s current liabilities has grown for 6 consecutive years.
- 5-year CAGR of +43.8%, indicating consistent growth.
- In FY2025, current liabilities increased 77.2% year-over-year.
- Ranks #47 out of 213 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current LiabilitiesValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $290.4M | +77.2% |
| FY2024 | $163.9M | +13.9% |
| FY2023 | $143.9M | +132.1% |
| FY2022 | $62.0M | +2.7% |
| FY2021 | $60.4M | +27.9% |
| FY2020 | $47.2M | +9.6% |
| FY2019 | $43.1M | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026